Fas ligand based immunotherapy: A potent and effective neoadjuvant with checkpoint inhibitor properties, or a systemically toxic promoter of tumor growth?
about
Fas ligand based immunotherapy: A potent and effective neoadjuvant with checkpoint inhibitor properties, or a systemically toxic promoter of tumor growth?
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@ast
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@en
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@nl
type
label
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@ast
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@en
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@nl
prefLabel
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@ast
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@en
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@nl
P1433
P1476
Fas ligand based immunotherapy ...... oxic promoter of tumor growth?
@en
P2093
Bellgrau D
Modiano JF
P304
P407
P577
2016-02-01T00:00:00Z